TY - JOUR
T1 - The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer's disease
AU - for the Alzheimer's Disease Neuroimaging Initiative, for the Shanghai Memory Study
AU - Lu, Jiaying
AU - Zhang, Zhengwei
AU - Wu, Ping
AU - Liang, Xiaoniu
AU - Zhang, Huiwei
AU - Hong, Jimin
AU - Clement, Christoph
AU - Yen, Tzu Chen
AU - Ding, Saineng
AU - Wang, Min
AU - Xiao, Zhenxu
AU - Rominger, Axel
AU - Shi, Kuangyu
AU - Guan, Yihui
AU - Zuo, Chuantao
AU - Zhao, Qianhua
N1 - Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - PURPOSE: Left-right asymmetry, an important feature of brain development, has been implicated in neurodegenerative diseases, although it's less discussed in typical Alzheimer's disease (AD). We sought to investigate whether asymmetric tau deposition plays a potential role in AD heterogeneity.METHODS: Two independent cohorts consisting of patients with mild cognitive impairment due to AD and AD dementia with tau PET imaging were enrolled [the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort with
18F-Flortaucipir, the Shanghai Memory Study (SMS) cohort with
18F-Florzolotau]. Based on the absolute global tau interhemispheric differences, each cohort was divided into two groups (asymmetric versus symmetric tau distribution). The two groups were cross-sectionally compared in terms of demographic, cognitive characteristics, and pathological burden. The cognitive decline trajectories were analyzed longitudinally.
RESULTS: Fourteen (23.3%) and 42 (48.3%) patients in the ADNI and SMS cohorts showed an asymmetric tau distribution, respectively. An asymmetric tau distribution was associated with an earlier age at disease onset (proportion of early-onset AD: ADNI/SMS/combined cohorts, p = 0.093/0.026/0.001) and more severe pathological burden (i.e., global tau burden: ADNI/SMS cohorts, p < 0.001/= 0.007). And patients with an asymmetric tau distribution were characterized by a steeper cognitive decline longitudinally (i.e., the annual decline of Mini-Mental Status Examination score: ADNI/SMS/combined cohorts, p = 0.053 / 0.035 / < 0.001).CONCLUSIONS: Asymmetry in tau deposition, which may be associated with an earlier age at onset, more severe pathological burden, and a steeper cognitive decline, is potentially an important characteristic of AD heterogeneity.
AB - PURPOSE: Left-right asymmetry, an important feature of brain development, has been implicated in neurodegenerative diseases, although it's less discussed in typical Alzheimer's disease (AD). We sought to investigate whether asymmetric tau deposition plays a potential role in AD heterogeneity.METHODS: Two independent cohorts consisting of patients with mild cognitive impairment due to AD and AD dementia with tau PET imaging were enrolled [the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort with
18F-Flortaucipir, the Shanghai Memory Study (SMS) cohort with
18F-Florzolotau]. Based on the absolute global tau interhemispheric differences, each cohort was divided into two groups (asymmetric versus symmetric tau distribution). The two groups were cross-sectionally compared in terms of demographic, cognitive characteristics, and pathological burden. The cognitive decline trajectories were analyzed longitudinally.
RESULTS: Fourteen (23.3%) and 42 (48.3%) patients in the ADNI and SMS cohorts showed an asymmetric tau distribution, respectively. An asymmetric tau distribution was associated with an earlier age at disease onset (proportion of early-onset AD: ADNI/SMS/combined cohorts, p = 0.093/0.026/0.001) and more severe pathological burden (i.e., global tau burden: ADNI/SMS cohorts, p < 0.001/= 0.007). And patients with an asymmetric tau distribution were characterized by a steeper cognitive decline longitudinally (i.e., the annual decline of Mini-Mental Status Examination score: ADNI/SMS/combined cohorts, p = 0.053 / 0.035 / < 0.001).CONCLUSIONS: Asymmetry in tau deposition, which may be associated with an earlier age at onset, more severe pathological burden, and a steeper cognitive decline, is potentially an important characteristic of AD heterogeneity.
KW - Age
KW - Alzheimer's disease
KW - Asymmetry
KW - Positron emission tomography
KW - Prognosis
KW - Tau
KW - tau Proteins/metabolism
KW - Humans
KW - Brain/pathology
KW - China
KW - Age of Onset
KW - Amyloid beta-Peptides
KW - Biomarkers
KW - Cognitive Dysfunction/diagnostic imaging
KW - Alzheimer Disease/pathology
KW - Positron-Emission Tomography/methods
UR - http://www.scopus.com/inward/record.url?scp=85154071004&partnerID=8YFLogxK
U2 - 10.1016/j.nicl.2023.103416
DO - 10.1016/j.nicl.2023.103416
M3 - 文章
C2 - 37137254
AN - SCOPUS:85154071004
SN - 2213-1582
VL - 38
SP - 103416
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
M1 - 103416
ER -